Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Recruiting now · Phase 1

Conditions studied: Suicide, Suicidal Ideation, Depression

In brief

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.

Key facts

Study ID
NCT06085937
Run by
Lindsay Maguire, MD
People needed
50
Starts
2024-05-01
Expected to finish
2027-04-01
Last updated by the study team
2026-04-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.